MedPath

Evaluation of Sleep Quality in Head and Neck Cancer Patients Throughout Treatment Course

Recruiting
Conditions
Malignant Head and Neck Neoplasm
Interventions
Other: Survey Administration
Registration Number
NCT05108233
Lead Sponsor
Thomas Jefferson University
Brief Summary

This study examines how head and neck cancer treatment affects quality of sleep over time and factors that contribute to sleep quality. Sleep plays a critical role in healing and quality of life, and recent studies investigating sleep disorders in head and neck cancer patients reveal sleep quality is a major determinant of post-treatment outcomes. Information from this study may help researchers better understand how treatment impacts sleep quality so that they can make changes that may help improve patient sleep quality.

Detailed Description

PRIMARY OBJECTIVES:

I. To describe the five (5) components of sleep quality in head and neck patients under different stages of post-op treatment and different environment.

II. To evaluate the effect of surgery, treatment and environment on the five (5) components of sleep quality in head and neck cancer patients.

SECONDARY OBJECTIVES:

I. To evaluate the association between the five (5) components of sleep quality and comorbid obstructive sleep apnea (STOP-BANG and Epworth Sleeping Scale) and depression (Patient Health Questionnaire-2 \[PHQ-2\]), under different stages of post-op treatment and different environment.

II. To evaluate the association between Fitbit actigraphy data (i.e. the 5th component of sleep quality) and the first 4 components of sleep quality for inpatients.

III. To compare the inpatient versus the outpatient responses on sleep hygiene at different time points of measurement.

EXPLORATORY OBJECTIVE:

I. To assess whether survey results warrant additional counseling or patient education.

OUTLINE:

COHORT 1-TP1: Patients complete surveys over 20 minutes on post-op day 3 and on day of discharge (or within 1 week).

COHORT 1-TP2: Patients complete surveys over 15 minutes at all regularly scheduled follow-up appointments (approximately 1 month, 3 months, 6 months, 12 months).

COHORT 2: Patients complete surveys over 15 minutes once.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Males and females
  • Adult at least 18 years old
  • Capable of giving informed consent
  • Diagnosed with head and neck cancer (previously untreated, any stage)
  • Treatment plan involves surgery
  • Willing to comply with all study procedures and be available for the duration of the study
  • English-speaking
Read More
Exclusion Criteria
  • Non-English speaking

  • Pre-existing sleep disorder defined below:

    • Obstructive sleep apnea
    • Insomnia
    • Narcolepsy
    • Restless leg syndrome
    • Rapid eye movement (REM) sleep behavior disorder
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Observational (survey)Survey AdministrationCOHORT 1-TP1: Patients complete surveys over 20 minutes on post-op day 3 and on day of discharge (or within 1 week). COHORT 1-TP2: Patients complete surveys over 15 minutes at all regularly scheduled follow-up appointments (approximately 1 month, 3 months, 6 months, 12 months). COHORT 2: Patients complete surveys over 15 minutes once.
Primary Outcome Measures
NameTimeMethod
Per-patient average score on Richards-Campbell Sleep QuestionnaireUp to study completion; approximately 12 months
Barriers to sleep qualityUp to study completion; approximately 12 months
Time in bedUp to study completion; approximately 12 months

The time difference between time to get into bed and time to get up, measured in minutes

Sleep latencyUp to study completion; approximately 12 months

How long it takes to sleep, measured in minutes.

Sleep maintenance latencyUp to study completion; approximately 12 months

How long it takes to fall back to sleep, measured in minutes.

Per-patient sum of scores on Epworth Sleepiness ScaleUp to study completion; approximately 12 months
Sleep hygieneUp to study completion; approximately 12 months
Number of nighttime awakeningUp to study completion; approximately 12 months
Per-patient sum of positive responses on STOP-BANGUp to study completion; approximately 12 months
Per-patient sum of scores on Patient Health Questionnaire-2Up to study completion; approximately 12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Thomas Jefferson University Hospital

🇺🇸

Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath